Search Results
Apr 09, 2026, 09:00 ET Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide
in Global Phase III Clinical Trials; Bi-weekly Dosing Regimen Significantly Enhances Patient ComplianceCurrently, as the world's first bi-weekly GLP-1RA to enter Phase III clinical research, Bofanglutide has advanced into the critical Phase III stage of its global
More news about: Gan & Lee Pharmaceuticals
Apr 09, 2026, 08:30 ET Bitmine Immersion Technologies (NYSE: BMNR) Announces Uplisting to New York Stock Exchange and Expansion of Share Repurchase Program to $4 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: Bitmine Immersion Technologies, Inc.
Apr 09, 2026, 08:16 ET DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer
cancer. The application is based on positive interim results from the pivotal Phase III clinical trial (Study DB-1303-O-3001). The DB-1303-O-3001 trial is a randomized, controlled, open-label, multicenter Phase III clinical trial conducted in China. It aims to evaluate the efficacy and safety of
More news about: DualityBio
Apr 09, 2026, 08:01 ET START Strengthens Dallas-Fort Worth Leadership with Dr. Salwan Al Mutar as Director of Clinical Research
cancer and biomarker-driven therapies.Throughout his career, Dr. Al Mutar has played a key role in advancing clinical research across Phase I-III studies, including first-in-human and combination therapy trials. He has served as a principal investigator on numerous industry- and investigator-sponsored
More news about: The START Center for Cancer Research
Apr 09, 2026, 07:55 ET DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer
cancer. The application is based on positive interim results from the pivotal Phase III clinical trial (Study DB-1303-O-3001). The DB-1303-O-3001 trial is a randomized, controlled, open-label, multicenter Phase III clinical trial conducted in China. It aims to evaluate the efficacy and safety of
More news about: DualityBio
Apr 09, 2026, 07:45 ET Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting
as well as thalamocortical neurons.1 The U.S. Drug Enforcement Agency (DEA) has designated Xywav as a Schedule III medicine. The DEA defines Schedule III drugs, substances, or chemicals as drugs with a moderate to low potential for physical and psychological dependence.1,2 Because
More news about: Jazz Pharmaceuticals plc
Apr 09, 2026, 07:00 ET AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
NCT07175038, up to 30 PAH and 10 ILD-PH patients, World Health Organization (WHO) functional class II and III, will receive ROC-101 in combination with standard of care therapy. The primary endpoint is change in pulmonary vascular resistance assessed via right
More news about: AllRock Bio
Apr 09, 2026, 07:00 ET Terra Quantum AG to go public in $3.25 billion SPAC deal
not be completed by MLAC II's business combination deadline and the potential failure to obtain an extension of the business combination deadline; (iii) the failure to satisfy the conditions to the consummation of the proposed business combination, including the approval of the proposed business combination
More news about: Terra Quantum
Apr 09, 2026, 07:00 ET Terra Quantum AG to go public in $3.25 billion SPAC deal
not be completed by MLAC II's business combination deadline and the potential failure to obtain an extension of the business combination deadline; (iii) the failure to satisfy the conditions to the consummation of the proposed business combination, including the approval of the proposed business combination
More news about: Terra Quantum
Apr 09, 2026, 06:20 ET Kelun-Biotech Approved by HKEX to Remove "B" Marker from Stock Code, Representing a New Stage of Development
partners, including MSD and Crescent Biopharma, steadily advancing the global development of relevant assets. Notably, MSD has evaluated 17 global Phase III clinical trials for sacituzumab tirumotecan (sac-TMT, 佳泰莱®), and multiple studies are approaching the data readout stage and further achieving
More news about: Kelun-Biotech
Apr 09, 2026, 05:00 ET Hamilton Dissolved Oxygen Sensors Achieve North American Ex Approval for Hazardous Environments
previously required specialized instrumentation for explosive atmospheres.The newly approved sensors are certified for use in Class I, II, and III hazardous locations and comply with internationally recognized standards for equipment protection by intrinsic safety. In addition to this new certification,
More news about: Hamilton Company
Apr 08, 2026, 19:21 ET Vistra Prices Private Offering of $4.0 Billion of Senior Notes
redeem existing indebtedness, including the Company's Senior Notes due 2027 and/or Term Loan B-3 Facility, (ii) for general corporate purposes and/or (iii) to pay fees and expenses related to the Offering.The Offering is expected to close on April 22, 2026, subject to customary closing conditions.The
More news about: Vistra Corp
Apr 08, 2026, 16:30 ET Catalyst Bancorp, Inc. Announces Agreement to Acquire Lakeside Bancshares, Inc.
governmental and regulatory approvals may delay the merger or result in the imposition of conditions that could cause the parties to abandon the merger; (iii) the risk that a condition to closing may not be satisfied; (iv) the timing to consummate the proposed merger; (v) the risk that the businesses will
More news about: Catalyst Bancorp, Inc.
Apr 08, 2026, 16:19 ET Students Play Key Role in Professional Tour at Shrub Oak International School and The Pines at Shrub Oak
support.Shrub Oak International School is accredited by:The National Independent Private Schools Association (NIPSA), Level III Therapeutic Certification, Academic Accreditation, with an Autism Endorsement;The Middle States Association Commission on
More news about: Shrub Oak International School
Apr 08, 2026, 16:15 ET SunTx Capital Partners' Portfolio Company, Suncrete, and Haymaker Acquisition Corp. 4, Successfully Complete Business Combination
wholly owned subsidiaries of Suncrete.Suncrete's Chief Executive Officer, Randall Edgar, and Executive Chairman of the Board, Ned N. Fleming, III, along with other members of the management team and board of directors, are expected to ring Nasdaq's closing bell on the afternoon of April 9, 2026."This
More news about: Suncrete, Inc.
Apr 08, 2026, 14:15 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN
receive, for each share of Thermon common stock, either: (i) $10.00 in cash and 0.6840 shares of CECO common stock, (ii) $63.89 in cash per share, or (iii) 0.8110 shares of CECO common stock per share.Click here for more information
More news about: Monteverde & Associates PC
Apr 08, 2026, 13:30 ET 3D Rendering Service Market to Reach USD 7.2 Billion by 2033 Driven by Expanding Adoption Across Architecture, Real Estate, Gaming, and Product Visualization Industries: Market Research Intellect
Channel Opener Market By Product (Type I (Small‑Molecule Therapeutics), Type II (Biologics and Monoclonal Antibodies), Type III (Cell and Gene Therapies), Type IV (Vaccines and Immune Modulators), Type V (RNA‑Based Therapeutics)), By Application (Oncology Treatment Channels, Rare
More news about: Market Research Intellect
Apr 08, 2026, 12:30 ET INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Super Micro Computer, Inc. (SMCI) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
significant portion of Super Micro's sales of servers were to companies based in China; (ii) these transactions violated U.S. export control laws; and (iii) there were material weaknesses in Super Micro's controls to ensure compliance with applicable export control laws and regulations.The Super
More news about: Robbins Geller Rudman & Dowd LLP
Apr 08, 2026, 11:12 ET INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit
with Anktiva to be cancer-free for the long term, when this has not been demonstrated"; (ii) the claim that Anktiva is a cancer vaccine was false; and (iii) ImmunityBio's Executive Chairman and Global Scientific and Medical Officer, defendant Dr. Patrick Soon-Shion, materially overstated Anktiva's capabilities.The
More news about: Robbins Geller Rudman & Dowd LLP
Apr 08, 2026, 11:00 ET Mesirow Expands Asia-Pacific Presence with Appointment of Mr. Manabu Ogi and Mr. Katsuya Fukushima to Lead New Tokyo Office
passive currency risk management products $214.27 billion, (ii) non-fx overlay strategies such as equitization and beta overlays $1.09 billion, and (iii) alpha strategies $1.76 billion. In all such cases, AUM is calculated based on notional value of currency investments. Additionally, AUM for alpha strategies
More news about: Mesirow Financial Holdings, Inc.
Apr 08, 2026, 09:07 ET PartsSource and WakeMed Collaborate to Achieve Clinical Asset Performance - Driving Productivity and Clinical Capacity Across Fleet
departments, a dedicated Children's Hospital and Rehabilitation Hospital, two exceptional Trauma Centers—a Level I Trauma Center in Raleigh and a Level III Trauma Center in Cary, and more than 175 physician and physical therapy practice offices. WakeMed's mission-driven team includes more than 12,800 employees,
More news about: PartsSource
Apr 08, 2026, 08:58 ET Marco's Pizza Accelerates West Coast Growth with 12-Unit Signed Agreement in California
This information excludes (i) international locations (including Puerto Rico); (ii) Franchised Stores not open for the entire 52-week period in 2024; (iii) special venue and non-traditional franchised locations; and (iv) Franchised Stores that closed in 2024. See Item 19 of our 2025 Franchise Disclosure
More news about: Marco's Pizza
Apr 08, 2026, 08:50 ET Vistra Announces Private Offering of Senior Notes
redeem existing indebtedness, including the Company's Senior Notes due 2027 and/or Term Loan B-3 Facility, (ii) for general corporate purposes and/or (iii) to pay fees and expenses related to the Offering.The Notes have not been registered under the Securities Act or the securities laws of any state
More news about: Vistra Corp
Apr 08, 2026, 08:47 ET Swain's Opens Friday: The First Auction House Built for Black and African Diaspora Art
Award–winning Chicago-born artist Zeph Farmby, DC-based mixed-media painter Jabari Jefferson, and multidisciplinary artist Lex Marie anchor Act II. Act III features the first documented collaboration between Blu Murphy and Ashley Nora—Keep Your Eyes on Me (2026)—alongside two works by Howard University lecturer
More news about: Swain's
Apr 08, 2026, 07:30 ET Littlejohn Capital Completes the Sale of Maysteel Industries
needs of a strong base of existing customers as we continue to capitalize on a strong pipeline of new activity." Angus C. Littlejohn III, President of Littlejohn Capital, said: "We acquired Maysteel to further develop its high-value products in new end markets and enhance its ability to
More news about: Littlejohn Capital